LDLR Antikörper (Extracellular Domain)

Produktnummer ABIN113461

Produktdetails anti-LDLR Antikörper

Target: LDLR (Low Density Lipoprotein Receptor (LDLR))

Bindungsspezifität: AA 184-195, Extracellular Domain

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser LDLR Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro))

Spezifität: The antibody reacts specifically with The LDL Receptor (160 kDa mature or glycosylated receptor, 120 kDa precursor or unglycosylated receptor) plays a key role in cellular cholesterol homeostasis. It does not inhibit binding of LDL.

Kreuzreaktivität (Details): Species reactivity (tested):Human.

Aufreinigung: Immunoaffinity Chromatography

Immunogen: Specific synthetic peptide (sequence not conserved in VLDL receptor and LRP) of the LDL receptor extracellular domain (epitope between residues 184-195, the linker region between repeats 4 and 5)

Anwendungsinformationen

Applikationshinweise: Flow Cytometry: 1/10. Immunobloting: 1/100-1/200. Recognizes the 160 kDa band of LDLR and a 120 kDa band ofthe LDLR precursor from Fibroblasts, Hepatocytes, and monocytic cells cultured in thepresence of lipoprotein-deficient serum. Immunohistochemistry: 1/20. Receptor Binding Studies.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.1 mg/mL

Buffer: PBS, 0.5 % BSA

Handhabung: Avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store the lyophilized antibody at -20 °C. Following reconstitution, the product ist stable at 2-8 °C for up one week or (in aliquots) at -20 °C for up to six months.

Referenzen für anti-LDLR Antikörper (ABIN113461)

Akazawa, Date, Morikawa, Murayama, Miyamoto, Kaga, Barth, Baumert, Dubuisson, Wakita: "CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection." in: Journal of virology, Vol. 81, Issue 10, pp. 5036-45, (2007) (PubMed).

Details zu LDLR

Target: LDLR (Low Density Lipoprotein Receptor (LDLR))

Andere Bezeichnung: LDLR (LDLR Produkte)

Synonyme: FH antikoerper, FHC antikoerper, LDLCQ2 antikoerper, Hlb301 antikoerper, LDLRA antikoerper, LDLA antikoerper, LDL receptor-2 antikoerper, fhc antikoerper, ldlcq2 antikoerper, ldlr antikoerper, ldlr2-a antikoerper, LDL receptor 1 antikoerper, ldlr-a antikoerper, ldlr-b antikoerper, low density lipoprotein receptor antikoerper, low density lipoprotein receptor a antikoerper, low density lipoprotein receptor S homeolog antikoerper, low density lipoprotein receptor L homeolog antikoerper, LDLR antikoerper, Ldlr antikoerper, ldlra antikoerper, ldlr.S antikoerper, ldlr.L antikoerper

Hintergrund: The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. Low density lipoprotein (LDL) is normally bound at the cell membrane and taken into the cell ending up in lysosomes where the protein is degraded and the cholesterol is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemiaSynonyms: LDL receptor, LDLR, Low-density lipoprotein receptor

Gen-ID: 3949

NCBI Accession: NP_000518

UniProt: P01130

Pathways: Hepatitis C, Lipid Metabolism